<DOC>
	<DOCNO>NCT00519532</DOCNO>
	<brief_summary>The objective open-label extension ass long-term effect 24-hour transdermal delivery rotigotine motor function , sleep quality , nocturnal non-motor symptom Parkinson 's disease . The long-term safety tolerability rotigotine transdermal patch also evaluate .</brief_summary>
	<brief_title>Long-term Extension RECOVER- Long-term Effect 24h Transdermal Delivery Rotigotine Subjects With Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Completion trial SP889 Ongoing serious adverse event assess related trial medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>NeuproÂ®</keyword>
	<keyword>Rotigotine</keyword>
	<keyword>Parkinson 's Disease</keyword>
</DOC>